SCHEMBL9897184

SCHEMBL9897184

Cc1cccc(C(C)C(=O)Nc2nc3ccccc3o2)c1-c1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.44
PRKDC P78527 1/20 0.41
ATM Q13315 1/20 0.41
ATR Q13535 1/20 0.41
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
POLB P06746 2/20 0.40
CASP6 P55212 1/20 0.40
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
USP2 O75604 1/20 0.39
SCD O00767 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9894873 0.76 NPC1 (0.42) PTGS2MEN1KMT2APOLBCASP6
SCHEMBL9894874 0.76 NPC1 (0.42) PTGS2MEN1KMT2APOLBCASP6
SCHEMBL9896932 0.76 NPC1 (0.42) PTGS2MEN1KMT2APOLBCASP6
SCHEMBL9895215 0.72 NPC1 (0.44) PTGS2MEN1KMT2APOLBCASP6
SCHEMBL9897188 0.72 PTPN2 (0.46) PTGS2MEN1KMT2APOLBCASP6
SCHEMBL9891923 0.71 KDM4E (0.59) MEN1KMT2APOLBNPC1RAB9A
SCHEMBL9894832 0.71 CSNK1D (0.70) PTGS2MEN1KMT2APOLBCASP6
SCHEMBL9896267 0.70 SMN1; SMN2 (0.42) PTGS2MEN1KMT2APOLBCASP6
SCHEMBL9894659 0.70 PTPN1 (0.42) MEN1KMT2ANPC1RAB9ATP53
SCHEMBL1464656 0.70 PTGS2 (0.49) PTGS2PRKDCATMATRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149718-A1 Amido Compounds P2RX7, P2RX3, P2RX2 PTGS2 1485/4885PRKDC 3681/4885ATM 3466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.